Comparison of Multiparametric MRI, [68Ga]Ga-PSMA-11 PET-CT, and Clinical Nomograms for Primary T and N Staging of

Omar Marek Tayara1, Kacper Pełka2,3, Jolanta Kunikowska2

  • 1Second Department of Urology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.

Cancers
|December 23, 2023
PubMed
Abstract

Insights

Multiparametric MRI (mpMRI) and prostate-specific membrane antigen (PSMA) PET-CT are complementary for prostate cancer staging. Combining these imaging techniques improves the detection of lymph node and other cancer spread.

Area of Science:

  • Oncology
  • Radiology
  • Nuclear Medicine

Background:

  • Multiparametric magnetic resonance imaging (mpMRI) is standard for prostate cancer staging but may miss small metastatic lymph nodes.
  • Prostate-specific membrane antigen positron emission tomography-computed tomography (PSMA PET-CT) shows promise for detecting non-enlarged metastatic lymph nodes, but requires further validation.

Purpose of the Study:

  • To compare the diagnostic performance of mpMRI and PSMA PET-CT in detecting lymph node involvement (LNI), extra-prostatic extension (EPE), and seminal vesicle involvement (SVI) in patients with intermediate-to-high-risk prostate cancer.
  • To evaluate the utility of clinical nomograms in conjunction with imaging for staging prostate cancer.

Main Methods:

  • Prospective, single-center study of 74 patients with intermediate-to-high-risk prostate cancer undergoing radical prostatectomy.
  • Pre-operative staging using mpMRI and PSMA PET-CT to assess LNI, EPE, and SVI.
  • Comparison of imaging performance against histopathology and assessment using clinical nomograms (MSKCC).

Main Results:

  • PSMA PET-CT demonstrated superior performance over mpMRI in detecting lymph node involvement (LNI).
  • mpMRI showed better accuracy than PSMA PET-CT in detecting seminal vesicle involvement (SVI).
  • While the MSKCC nomogram performed well, decision curve analysis indicated that mpMRI and PSMA PET-CT offered greater net benefit for detecting SVI and LNI, respectively.

Conclusions:

  • Multiparametric MRI and [68Ga]Ga-PSMA-11 PET-CT are complementary imaging modalities.
  • Concomitant use of mpMRI and PSMA PET-CT enhances primary T and N staging accuracy in prostate cancer.